Literature DB >> 27641718

Local versus general anaesthesia for adults undergoing pars plana vitrectomy surgery.

Ana Licina1, Sharan Sidhu, Jing Xie, Crispin Wan.   

Abstract

BACKGROUND: Vitrectomy surgery is one of the commonest ophthalmic procedures performed across the world. It may be performed using general or local anaesthesia encompassing regional or topical anaesthesia depending on a number of factors, including patient suitability, and patient, surgeon or anaesthetist preference. There have so far been no evidence-based recommendations on the best form of anaesthesia for this intervention. There is no clear collated evidence base as to the best type of anaesthesia to reduce harm, and provide best surgical conditions and optimal outcome for patients.
OBJECTIVES: To compare local with general anaesthesia for adults undergoing pars plana vitrectomy. SEARCH
METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library and the reference lists of updated studies on the 25th of July 2016; MEDLINE via Ovid SP (1972 to July 2016) and Embase via Ovid SP (1972 to July 2016). In addition we searched the metaRegister of Controlled Trials (mRCT), ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) in July 2016. We searched the proceedings of the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) up to July 2016 for information about other relevant studies.We also searched appropriate databases for ongoing reviews. We did not apply any language restriction. We assessed the search as up-to-date on the 25th of July 2016. SELECTION CRITERIA: We planned to include all published randomized controlled trials (RCTs) involving comparison of different modalities of local anaesthesia with general anaesthesia for pars plana vitrectomy. We considered the following different modalities of local anaesthesia: sub-Tenon's anaesthesia, retrobulbar anaesthesia, topical anaesthesia, peribulbar anaesthesia. We planned to include cluster-randomized controlled trials. We excluded quasi-RCT trials. DATA COLLECTION AND ANALYSIS: Two review authors conducted independent searches and assessed identified studies for inclusion according to the prespecified selection criteria. Two review authors assessed trial quality and planned to extract the data. MAIN
RESULTS: We found no eligible studies that met our inclusion criteria and were therefore unable to perform a meta-analysis or conduct a methodological quality assessment. AUTHORS'
CONCLUSIONS: This systematic review failed to locate relevant clinical evidence to support or refute a pars plana vitrectomy performed with various modalities of local anaesthesia versus general anaesthesia. Good-quality clinical trials are needed to define the role of local versus general anaesthesia for pars plana vitrectomy.

Entities:  

Year:  2016        PMID: 27641718      PMCID: PMC6457833          DOI: 10.1002/14651858.CD009936.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  28 in total

1.  Cost analysis in vitrectomy: monitored anesthesia care and general anesthesia.

Authors:  J J Huang; S Fogel; M Leavell
Journal:  AANA J       Date:  2001-04

2.  Death potentially secondary to sub-Tenon's block.

Authors:  C L Quantock; T Goswami
Journal:  Anaesthesia       Date:  2007-02       Impact factor: 6.955

3.  Visual experiences during vitreous surgery under regional anesthesia: a multicenter study.

Authors:  Colin S H Tan; Usman Mahmood; Paul D O'Brien; Stephen Beatty; Alvin K H Kwok; Vincent Y W Lee; Kah-Guan Au Eong
Journal:  Am J Ophthalmol       Date:  2005-12       Impact factor: 5.258

4.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

5.  Vitrectomy: a pars plana approach. Technical improvements and further results.

Authors:  R Machemer; J M Parel; E W Norton
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1972 Mar-Apr

6.  The development of pars plana vitrectomy: a personal account.

Authors:  R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-08       Impact factor: 3.117

7.  Patients' descriptions of visual sensations during pars plana vitrectomy under retrobulbar anesthesia.

Authors:  Eiko Sugisaka; Kei Shinoda; Susumu Ishida; Yutaka Imamura; Yoko Ozawa; Hajime Shinoda; Kotaro Suzuki; Kazuo Tsubota; Makoto Inoue
Journal:  Am J Ophthalmol       Date:  2007-06-18       Impact factor: 5.258

8.  Outpatient and abbreviated hospitalization for vitreoretinal surgery.

Authors:  D Wilson; C C Barr
Journal:  Ophthalmic Surg       Date:  1990-02

9.  Comparison of topical anesthesia and peribulbar anesthesia for 23-gauge vitrectomy without sedation.

Authors:  Deepankur Mahajan; Siddarth Sain; Shoryavardhan Azad; Tarun Arora; Rajvardhan Azad
Journal:  Retina       Date:  2013 Jul-Aug       Impact factor: 4.256

Review 10.  Meta-analysis: pitfalls and hints.

Authors:  T Greco; A Zangrillo; G Biondi-Zoccai; G Landoni
Journal:  Heart Lung Vessel       Date:  2013
View more
  10 in total

1.  Evaluating the effectiveness of localized sub-Tenon's anesthesia in 23-gauge vitreoretinal surgery.

Authors:  Atilla Alpay; Tuncer Güney
Journal:  Int Ophthalmol       Date:  2020-09-09       Impact factor: 2.031

2.  Patients' Experience of Anxiety and Pain during Retrobulbar Injections prior to Vitrectomy.

Authors:  Michael Mimouni; Hamza Abualhasan; Kamal Mtanes; Fares Mazzawi; Yoreh Barak
Journal:  J Ophthalmol       Date:  2019-07-31       Impact factor: 1.909

3.  Vitreoretinal Surgery Under Sub-Tenon's Block and Conscious Sedation in a Patient with Brugada Syndrome: A Case Report and Literature Review.

Authors:  Chandra M Kumar; Shashi B Vohra; Reza Farahmand Rad
Journal:  Anesth Pain Med       Date:  2021-11-07

4.  Anesthetic Approach in Ambulatory Vitrectomy: Peribulbar Block vs. Balanced General Anesthesia.

Authors:  Bárbara Gouveia; Leonardo Ferreira; Paula Maia
Journal:  Anesthesiol Res Pract       Date:  2022-03-28

5.  Preoperative oral diazepam for intraoperative blood pressure stabilisation in hypertensive patients undergoing vitrectomy under retrobulbar nerve block anaesthesia: study protocol for a randomised controlled trial.

Authors:  Tianwei Qian; Qiaoyun Gong; Chong Chen; Xia Wu; Lin Xue; Ying Fan; Weijun Wang; Zhihua Zhang; Hui Cao; Xun Xu
Journal:  Trials       Date:  2022-09-02       Impact factor: 2.728

6.  Cost analysis of vitrectomy under local versus general anesthesia in a developing country.

Authors:  Gilbert Ws Simanjuntak; Ari Djatikusumo; Asri Adisasmita; Mardiati Nadjib; Hhb Mailangkay; Nazimul Hussain
Journal:  Clin Ophthalmol       Date:  2018-10-10

7.  Patient quality of recovery on the day of surgery after propofol total intravenous anesthesia for vitrectomy: A randomized controlled trial.

Authors:  Se Hee Na; Kyu Hee Jeong; Dahae Eum; Jin Ha Park; Min-Soo Kim
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

8.  Anesthetic management with a neuromuscular relaxant and sugammadex in a patient with Prader-Willi syndrome: A case report.

Authors:  Kyung Woo Kim; Seung Hwan Kim; Eun Jin Ahn; Hyo Jin Kim; Hey Ran Choi; Si Ra Bang
Journal:  SAGE Open Med Case Rep       Date:  2020-06-03

9.  Preventive Analgesia, Hemodynamic Stability, and Pain in Vitreoretinal Surgery.

Authors:  Michał Jan Stasiowski; Aleksandra Pluta; Anita Lyssek-Boroń; Magdalena Kawka; Lech Krawczyk; Ewa Niewiadomska; Dariusz Dobrowolski; Robert Rejdak; Seweryn Król; Jakub Żak; Izabela Szumera; Anna Missir; Przemysław Jałowiecki; Beniamin Oskar Grabarek
Journal:  Medicina (Kaunas)       Date:  2021-03-12       Impact factor: 2.430

10.  COMPARISON OF RETROBULBAR, SUB-TENON ANESTHESIA AND MEDIAL CANTHUS EPISCLERAL ANESTHESIA FOR 25-GAUGE POSTERIOR VITRECTOMY.

Authors:  Derri Roman-Pognuz; Giuseppe Scarpa; Gianni Virgili; Erik Roman-Pognuz; Giacomo Paluzzano; Fabiano Cavarzeran
Journal:  Retina       Date:  2022-01-01       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.